等待開盤 04-02 09:30:00 美东时间
+0.260
+3.90%
Allot Ltd. (NASDAQ: ALLT, TASE: ALLT) has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (SEC). The report, containing audited financial statements, is available on the SEC's website and Allot's investor relations website. Shareholders can request a hard copy free of charge. Allot provides innovative cybersecurity and network intelligence solutions for service pro...
03-27 15:25
Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of Security-as-a-Service and network intelligence solutions, announced that its CEO, Eyal Harari, will attend the 38th Annual Roth Conference in Laguna Niguel, CA on March 23-24, 2026. Mr. Harari will meet with institutional investors in one-on-one sessions. To schedule a meeting, interested parties should contact the conference organizers or Allot’s investor relations team. Allot s...
03-16 10:58
Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading provider of Security-as-a-Service (SECaaS) and network intelligence solutions, announced that its CEO, Eyal Harari, will meet with institutional investors at the Cantor Fitzgerald Global Technology Conference in New York City on March 11, 2026. Allot’s management is available for one-on-one meetings, and investors can schedule appointments through Cantor Fitzgerald Representatives or Allot’s invest...
03-04 10:37
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从47美元升至49美元;Citizens:维持Ironwood医药"跑赢大市"评级,目标价从8美元升至10美元
02-27 11:07
Allot (NASDAQ:ALLT) just disclosed its Q4 earnings on Wednesday, February 25, 2...
02-25 19:32
Companies Reporting Before The Bell • Clear Secure (NYSE:YOU) is expected to re...
02-25 19:11
Shares of software companies are trading lower after Citrini Research published...
02-24 04:32
今日重点评级关注:HC Wainwright & Co.:维持Soleno Therapeutics"买入"评级,目标价从110美元升至120美元;富国银行:维持Soleno Therapeutics"超配"评级,目标价从106美元升至114美元
01-21 11:42
Needham analyst Matthew Calitri reiterates Allot (NASDAQ:ALLT) with a Buy and maintains $12.5 price target.
01-20 19:17
今日重点评级关注:HC Wainwright & Co.:维持Enlivex Therapeutics"买入"评级,目标价从7美元升至13美元;BTIG:维持Oruka Therapeutics"买入"评级,目标价从63美元升至73美元
01-13 10:18